Linda Mol

Netherlands Comprehensive Cancer Organisation — Netherlands

Medicine · Health Sciences

25h-index4.2kcitations63works12.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(44), Gastric Cancer Management and Outcomes(19), Cancer Treatment and Pharmacology(15), Genetic factors in colorectal cancer(14), Hepatocellular Carcinoma Treatment and Prognosis(12)

Publications62 total

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group
Annals of Oncology·2024· 12 citedOpen Access
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial
Journal of Clinical Oncology·2023· 36 citedOpen Access
Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: The randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG).
Journal of Clinical Oncology·2023· 5 cited
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
Clinical Colorectal Cancer·2022· 4 citedOpen Access
The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer
Modern Pathology·2022· 7 citedOpen Access
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
BMC Cancer·2022· 9 citedOpen Access
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer
Clinical Colorectal Cancer·2022· 6 citedOpen Access
Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment
JAMA Surgery·2021· 51 citedOpen Access
Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer
Cells·2020· 17 citedOpen Access
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
British Journal of Cancer·2020· 25 citedOpen Access
Abstract 6487: Circulating tumor cells, tumor- and endothelium- derived extracellular vesicles, but not circulating endothelial cells associate with poor prognosis in colorectal cancer
Cancer Research·2020
Updated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch colorectal cancer group
Annals of Oncology·2019
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
˜The œLancet. Gastroenterology & hepatology·2019· 312 citedOpen Access
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group
Clinical Colorectal Cancer·2019· 5 cited
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
PLoS ONE·2018· 8 citedOpen Access
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group
Annals of Oncology·2017· 81 cited
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
European Journal of Cancer·2017· 75 cited
Clinical Trial Performance in Metastatic Colorectal Cancer: An Evaluation of Participating Centers in the CAIRO Studies of the Dutch Colorectal Cancer Group
Cancer clinical trials·2017
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
European Journal of Cancer·2017· 26 cited
Quality aspects of Dutch colorectal cancer trials
Data Archiving and Networked Services (DANS)·2017Open Access
page 1 of 4Next →

Frequent Co-authors

Cornelis J.A. Punt(39), Miriam Koopman(33), Lieke H. J. Simkens(12), Johannes H.W. de Wilt(10), Ninja Antonini(8), O. J. L. Loosveld(8), Geert-Jan Creemers(7), Maartje Los(7), Pieter J. Tanis(6), Dirkje W. Sommeijer(6), Steven Teerenstra(6), Mathijs P. Hendriks(6), C. J. Rodenburg(5), Allert H. Vos(5), Henderik L. van Westreenen(5), Daan ten Bokkel Huinink(5), Huib A. Cense(5), Esther C. J. Consten(5), Geert‐Jan Creemers(5), Erwin van der Harst(5)